Ebdarokimab
Akeso Biopharma
['psoriasis', 'imab ']
phase 1 data shows ebdarokimab (il12/23i) safe and well tolerated in moderate to severe plaque psoriasis patients. abs 0752 #acr22 
Passionately curious rheumatologist, world traveler, wife, mother, sister, daughter, friend, dog lover. Believer in scientific method & evidence based medicine.